Skip to content

The chiral energy doppler ultrasound is used to predict the treatment of biologic agents

The chiral energy doppler ultrasound is used to predict the treatment of biologic agents

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-17011297
Enrollment
Unknown
Registered
2017-05-04
Start date
2017-05-01
Completion date
Unknown
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

Observation group :Biological agents

Sponsors

Tianjin first central hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 65 years old, diagnosed RA (according to the American rheumatism association published 2010 RA diagnosis standard), moderately severe activities (DAS28 acuity 3.2 [1]), at least involvement with a palm or nearly knuckles, all patients signed the informed consent.

Exclusion criteria

Exclusion criteria: hand received intra-articular hormone injections whethin last three months, potential tuberculosis and other infectious disease, merge with other liver, kidney, heart, brain, lung, and blood system of severe disease, pregnancy or lactation, and participate in other clinical research, any due to other reasons are not suitable for the participants

Design outcomes

Primary

MeasureTime frame
CRP;ESR;The number of joint pain joints;Swelling joint quantity;

Countries

China

Contacts

Public ContactLi Yuan

Tianjin first central hospital rheumatoid immunology department

etigerli@126.com+86 13752270575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026